Effectiveness and tolerance of Janus kinase inhibitors for the treatment of recalcitrant atopic dermatitis in a real-life French multicenter adult cohort-Reference-Cited by-同舟云学术

Effectiveness and tolerance of Janus kinase inhibitors for the treatment of recalcitrant atopic dermatitis in a real-life French multicenter adult cohort

Published:2023-04 Issue:4 Volume:88 Page:900-904
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Vanlerberghe Julia,Dezoteux Frédéric,Martin Claire,Jachiet Marie,Soria Angèle,Tétart Florence,Modeste-Duval Anne-Bénédicte,Bursztejn Anne-Claire,Misery Laurent,Aubin François,Lasek Audrey,Leleu Camille,Du-Thanh Aurélie,Pasteur Justine,Pralong Pauline,Nosbaum Audrey,Droitcourt Catherine,Viguier Manuelle,Tauber Marie,Seneschal Julien,Barbarot Sébastien,Staumont-Sallé Delphine

Publisher

Elsevier BV

Subject

Dermatology

Reference4 articles.

1. Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials;Guttman-Yassky;Lancet,2021

2. Efficacy and safety of upadacitinib vs dupilumab in adults with moderate-to-severe atopic dermatitis: a randomized clinical trial;Blauvelt;JAMA Dermatol,2021

3. Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials;Simpson;Br J Dermatol,2020

4. Efficacy and safety of baricitinib combined with topical corticosteroids for treatment of moderate to severe atopic dermatitis: a randomized clinical trial;Reich;JAMA Dermatol,2020

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Practical Use of Upadacitinib in Patients with Severe Atopic Dermatitis in a Real-World Setting: A Systematic Review;Clinical, Cosmetic and Investigational Dermatology;2024-03

2. Efectividad y seguridad del baricitinib en la dermatitis atópica en la práctica clínica: estudio retrospectivo multicéntrico de cuatro hospitales andaluces (España);Actas Dermo-Sifiliográficas;2024-02

3. The efficacy and immunological effects of upadacitinib in the treatment of moderate-to-severe Chinese atopic dermatitis patients;International Immunopharmacology;2023-12

4. Quoi de neuf en thérapeutique dermatologique ?;Annales de Dermatologie et de Vénéréologie - FMC;2023-12

5. Impact of Baricitinib on Patients’ Quality of Life after One Year of Treatment for Atopic Dermatitis in Real-World Practice: Results of the Observatory of Chronic Inflammatory Skin Diseases Registry;Acta Dermato-Venereologica;2023-10-06